✦ LIBER ✦
A phase II study of 18F-fluorodeoxyglucose PET–CT in non-small cell lung cancer patients receiving erlotinib (Tarceva®); objective and symptomatic responses at 6 and 12 weeks
✍ Scribed by M.E.R. O’Brien; J.S. Myerson; J.I.G. Coward; M. Puglisi; L. Trani; A. Wotherspoon; B. Sharma; G. Cook; S. Ashley; R. Gunapala; S. Chua; S. Popat
- Book ID
- 116430925
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 270 KB
- Volume
- 48
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.